Produkty 1338549-02-2

CAS 1338549-02-2 występuje w naszej ofercie pod nazwami: Methylprednisolone EP Impurity D, Methylprednisolone Impurity 4（Methylprednisolone EP Impurity D）, (6alpha,11beta)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al, (6a,11β)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, MedChemExpress. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 2,5g, 250mg.

Methylprednisolone EP Impurity D
Chemat Brand
  • opakowanie: on request
  • Warianty: 2
Zobacz produkt
Methylprednisolone Impurity 4（Methylprednisolone EP Impurity D）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
(6alpha,11beta)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al
TRC
  • opakowanie: 2,5g, 250mg
  • Warianty: 2
Zobacz produkt
(6a,11β)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al
MedChemExpress
  • opakowanie: 1 g, 500 mg, 100 mg
  • Warianty: 3
od 1945,09
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2Z)-2-hydroxy-2-[(6S,8S,9S,10R,11S,13S,14S)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]acetaldehyde (CAS 1338549-02-2) to związek chemiczny o wzorze sumarycznym C22H28O4 i masie molowej 356.5 g/mol. Nazwa systematyczna IUPAC: (2Z)-2-hydroxy-2-[(6S,8S,9S,10R,11S,13S,14S)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]acetaldehyde. InChIKey: XYGYYRSXRDASPZ-MAFKTLPYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H28O4
Masa molowa356.5 g/mol
Nazwa IUPAC(2Z)-2-hydroxy-2-[(6S,8S,9S,10R,11S,13S,14S)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ylidene]acetaldehyde
InChIKeyXYGYYRSXRDASPZ-MAFKTLPYSA-N
SMILESC[C@H]1C[C@H]2[C@@H]3CC/C(=C(\C=O)/O)/[C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Methylprednisolone EP Impurity D, Methylprednisolone Impurity 6, (6a,11b)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al, (EZ)-11|A,20-dihydroxy-6|A-methylpregna-1,4,17(20)triene-3,21-dione, (6alpha,11beta)-11,20-Dihydroxy-6-methyl-3-oxopregna-1,4,17(20)-trien-21-al
Izomery (ten sam wzór sumaryczny)
(8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one C22H28O4
1-(3,4-dimethoxyphenyl)-3-ethyl-5,6-dimethoxy-2-methyl-2,3-dihydro-1H-indene C22H28O4
[(6S,8R,9S,10R,13S,14S,17R)-17-ethynyl-6-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C22H28O4
(8S,10S,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one C22H28O4
(1S,2S,8S,10S,11S,14R,15S,17S)-14-acetyl-14-hydroxy-2,8,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
(1S,2S,10S,11S,13R,14R,15S,17S)-14-acetyl-14-hydroxy-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
(1S,2S,11S,13R,14S,15S,17S)-14-(2-hydroxyacetyl)-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
(6S,8S,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione C22H28O4
[(6R,8R,9S,10R,13S,14S,17R)-17-ethynyl-6-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C22H28O4
(8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione C22H28O4
(2S,10S,11S,14R,15S)-14-acetyl-14-hydroxy-2,13,15-trimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C22H28O4
methyl 2-[(5-tert-butyl-2-methylphenyl)methoxymethyl]-6-methoxybenzoate C22H28O4